Medeon Biodesign (ROCO:6499) Change In Receivables : NT$12.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Change In Receivables?

Medeon Biodesign's change in receivables for the quarter that ended in Mar. 2024 was NT$13.4 Mil. It means Medeon Biodesign's Accounts Receivable declined by NT$13.4 Mil from Sep. 2023 to Mar. 2024 .

Medeon Biodesign's change in receivables for the fiscal year that ended in Dec. 2022 was NT$16.7 Mil. It means Medeon Biodesign's Accounts Receivable declined by NT$16.7 Mil from Dec. 2021 to Dec. 2022 .

Medeon Biodesign's Accounts Receivable for the quarter that ended in Mar. 2024 was NT$32.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Medeon Biodesign's Days Sales Outstanding for the three months ended in Mar. 2024 was 61.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Medeon Biodesign's liquidation value for the three months ended in Mar. 2024 was NT$1,591.9 Mil.

Medeon Biodesign Change In Receivables Historical Data

The historical data trend for Medeon Biodesign's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Change In Receivables Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-10.03

-22.09

-92.74

37.90

16.69

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Change In Receivables	Get a 7-Day Free Trial															18.51	8.04	8.35	-8.84	13.43

Medeon Biodesign Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$12.9 Mil.

Medeon Biodesign (ROCO:6499) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Medeon Biodesign's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	32.003	/	47.141	*	91
=	61.95

2. In Ben Graham's calculation of liquidation value, Medeon Biodesign's accounts receivable are only considered to be worth 75% of book value:

Medeon Biodesign's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1940.451	-	379.695	+	0.75 * 32.003	+	0.5 * 14.244
=	1,591.9

Medeon Biodesign Change In Receivables Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines